Can less be more? new trial aims to cut side effects in HPV throat cancer
NCT ID NCT03621696
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving less intense treatment after surgery for HPV-related throat cancer can reduce side effects like weight loss and the need for a feeding tube. 63 patients had surgery and then received either lower-dose radiation or no radiation, depending on their risk level. The goal was to keep the cancer from coming back while making treatment easier to tolerate.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cisplatin (chemotherapy) and radiation therapy (IMRT or IMPT)
- What this could lead to
- If successful, this approach could lead to a less toxic treatment plan for HPV-related throat cancer, reducing weight loss, feeding tube use, and other side effects without sacrificing cancer control.
- What could go wrong
- This is a small, single-arm Phase 2 trial with no comparison group, so it cannot prove that the reduced treatment is as effective as standard care. The results may not apply to all patients, and there is still a risk of cancer recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV RELATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.